News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
204,962 Results
Type
Article (9529)
Company Profile (44)
Press Release (195385)
Multimedia
Podcasts (10)
Webinars (3)
Section
Business (56567)
Career Advice (1135)
Deals (12938)
Drug Delivery (21)
Drug Development (21321)
Employer Resources (50)
FDA (4204)
Job Trends (4588)
News (96649)
Policy (8098)
Tag
Academia (1029)
Academic (1)
Accelerated approval (13)
Adcomms (3)
Allergies (18)
Alliances (17991)
ALS (34)
Alzheimer's disease (552)
Antibody-drug conjugate (ADC) (80)
Approvals (4295)
Artificial intelligence (220)
Autoimmune disease (32)
Automation (12)
Bankruptcy (104)
Best Places to Work (4018)
BIOSECURE Act (2)
Biosimilars (48)
Biotechnology (33)
Bladder cancer (54)
Brain cancer (32)
Breast cancer (195)
Cancer (1691)
Cardiovascular disease (79)
Career advice (929)
Career pathing (17)
CAR-T (61)
CDC (6)
Celiac Disease (1)
Cell therapy (173)
Cervical cancer (8)
Clinical research (17505)
Collaboration (639)
Compensation (130)
Complete response letters (12)
COVID-19 (899)
CRISPR (29)
C-suite (226)
Cystic fibrosis (62)
Data (1968)
Denatured (1)
Depression (35)
Diabetes (101)
Diagnostics (3845)
Digital health (10)
Diversity (3)
Diversity, equity & inclusion (9)
Drug discovery (101)
Drug pricing (31)
Drug shortages (3)
Duchenne muscular dystrophy (33)
Earnings (18780)
Editorial (3)
Employer branding (10)
Employer resources (42)
Events (27796)
Executive appointments (308)
FDA (5064)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (8)
Funding (472)
Gene editing (56)
Generative AI (23)
Gene therapy (121)
GLP-1 (175)
Government (1161)
Guidances (127)
Healthcare (5659)
HIV (6)
Huntington's disease (6)
IgA nephropathy (22)
Immunology and inflammation (49)
Immuno-oncology (16)
Indications (32)
Infectious disease (980)
Inflammatory bowel disease (63)
Inflation Reduction Act (2)
Influenza (43)
Intellectual property (78)
Interviews (208)
IPO (7009)
IRA (5)
Job creations (681)
Job search strategy (742)
JPM (10)
Kidney cancer (3)
Labor market (20)
Layoffs (72)
Leadership (9)
Legal (1672)
Liver cancer (22)
Longevity (4)
Lung cancer (222)
Lymphoma (115)
Machine learning (18)
Management (15)
Manufacturing (182)
MASH (33)
Medical device (3448)
Medtech (3461)
Mergers & acquisitions (6489)
Metabolic disorders (244)
Multiple sclerosis (33)
NASH (3)
Neurodegenerative disease (89)
Neuropsychiatric disorders (16)
Neuroscience (879)
Neurotech (1)
NextGen: Class of 2026 (1964)
Non-profit (1198)
Now hiring (13)
Obesity (105)
Opinion (81)
Ovarian cancer (31)
Pain (47)
Pancreatic cancer (85)
Parkinson's disease (76)
Partnered (8)
Patents (162)
Patient recruitment (102)
Peanut (9)
People (18024)
Pharmaceutical (4)
Pharmacy benefit managers (5)
Phase 1 (5817)
Phase 2 (7929)
Phase 3 (5584)
Pipeline (1597)
Policy (36)
Postmarket research (522)
Preclinical (3193)
Press Release (26)
Prostate cancer (88)
Psychedelics (9)
Radiopharmaceuticals (113)
Rare diseases (253)
Real estate (1522)
Recruiting (25)
Regulatory (6435)
Reports (17)
Research institute (1037)
Resumes & cover letters (265)
Rett syndrome (5)
RNA editing (5)
RSV (20)
Schizophrenia (49)
Series A (67)
Series B (44)
Service/supplier (1)
Sickle cell disease (32)
Special edition (4)
Spinal muscular atrophy (40)
Sponsored (13)
Startups (1286)
State (1)
Stomach cancer (1)
Supply chain (24)
Tariffs (16)
The Weekly (9)
Vaccines (232)
Venture capital (7)
Weight loss (49)
Women's health (16)
Worklife (7)
Date
Today (12)
Last 7 days (183)
Last 30 days (624)
Last 365 days (8973)
2026 (880)
2025 (9067)
2024 (10802)
2023 (13444)
2022 (17110)
2021 (18863)
2020 (17967)
2019 (14090)
2018 (10613)
2017 (9940)
2016 (9489)
2015 (11288)
2014 (7948)
2013 (6548)
2012 (6964)
2011 (7208)
2010 (6273)
Location
Africa (215)
Alabama (13)
Alaska (4)
Arizona (77)
Arkansas (5)
Asia (10948)
Australia (1925)
California (3384)
Canada (877)
China (270)
Colorado (80)
Connecticut (161)
Delaware (99)
Europe (25444)
Florida (538)
Georgia (80)
Hawaii (1)
Idaho (17)
Illinois (223)
India (22)
Indiana (142)
Iowa (4)
Japan (121)
Kansas (31)
Kentucky (8)
Louisiana (6)
Maine (49)
Maryland (368)
Massachusetts (2256)
Michigan (101)
Minnesota (157)
Mississippi (4)
Missouri (42)
Montana (9)
Nebraska (6)
Nevada (48)
New Hampshire (17)
New Jersey (902)
New Mexico (11)
New York (1032)
North Carolina (433)
North Dakota (4)
Northern California (1528)
Ohio (113)
Oklahoma (4)
Oregon (9)
Pennsylvania (611)
Puerto Rico (2)
Rhode Island (9)
South America (292)
South Carolina (15)
Southern California (1390)
Tennessee (60)
Texas (654)
United States (11980)
Utah (176)
Vermont (1)
Virginia (81)
Washington D.C. (22)
Washington State (301)
West Virginia (1)
Wisconsin (60)
204,962 Results for "applied molecular transport llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. announced the closing of its previously announced transaction pursuant to which AMT will merge with Cyclo Therapeutics in an all-stock transaction.
December 27, 2023
·
5 min read
Business
Applied Molecular Transport Reports Third Quarter 2023 Financial Results
Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2023.
November 9, 2023
·
5 min read
Press Releases
LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
January 23, 2026
·
4 min read
Business
Applied Molecular Transport Reports Second Quarter 2023 Financial Results
Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2023.
August 14, 2023
·
5 min read
Press Releases
Longhorn Vaccines and Diagnostics Validates Efficacy of PrimeStore® Molecular Transport Medium (MTM) to Inactivate Deadly Pathogens
May 8, 2025
·
3 min read
Press Releases
Microbix Presents Molecular Pathology Platform Results
February 4, 2026
·
5 min read
Business
Applied Molecular Transport Reports First Quarter 2023 Financial Results
Applied Molecular Transport Inc., a biopharmaceutical company, reported financial results for the first quarter ended March 31, 2023.
May 11, 2023
·
5 min read
Press Releases
Synthego Announces Entry into Molecular Biology and Clinical Diagnostic Reagents Market
January 13, 2026
·
3 min read
Press Releases
Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication
May 16, 2025
·
7 min read
Press Releases
Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models
December 15, 2025
·
2 min read
1 of 20,497
Next
